This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 7, No 6 (2018): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9043, first published .
Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care

Authors of this article:

Geoff McCombe1 Author Orcid Image ;   Davina Swan1 Author Orcid Image ;   Eileen O’Connor2 Author Orcid Image ;   Gordana Avramovic2 Author Orcid Image ;   Peter Vickerman3 Author Orcid Image ;   Zoe Ward3 Author Orcid Image ;   Julian Surey4 Author Orcid Image ;   Juan Macías5 Author Orcid Image ;   John S Lambert2 Author Orcid Image ;   Walter Cullen1 Author Orcid Image
Article Authors Cited by (9) Tweetations (15) Metrics

Journals

  1. Murtagh R, Swan D, O'Connor E, McCombe G, Lambert J, Avramovic G, Cullen W. Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study. Interactive Journal of Medical Research 2018;7(2):e10313 View
  2. Sin M, Querol V, Delás J. Ecografía por ultrasonografía en la enfermedad por hígado graso no alcohólico. Atención Primaria 2020;52(9):664 View
  3. Connolly S, Avramovic G, Cullen W, McHugh T, O’Connor E, Mc Combe G, Crowley D, Naughton A, Horan A, Lambert J. HepCare Ireland—a service innovation project. Irish Journal of Medical Science (1971 -) 2021;190(2):587 View
  4. Pozza R, McCoy-Hill C, Hall K, Hefner A, Wilgers K, Tapelband J, Masroor M, Hassanein T. Eradicating hepatitis C virus. The Nurse Practitioner 2019;44(11):16 View
  5. Nic An Riogh E, Swan D, McCombe G, O’Connor E, Avramovic G, Macías J, Oprea C, Story A, Surey J, Vickerman P, Ward Z, Lambert J, Tinago W, Ianache I, Iglesias M, Cullen W. Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care. Journal of Antimicrobial Chemotherapy 2019;74(Supplement_5):v31 View
  6. Avramovic G, Reilly M, Cullen W, Macías J, McCombe G, McHugh T, Oprea C, Story A, Surey J, Sabin C, Bivegete S, Vickerman P, Walker J, Ward Z, Lambert J. HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities. International Journal of Infectious Diseases 2020;101:374 View
  7. McCombe G, Swan D, Lambert J, O’Connor E, Ward Z, Vickerman P, Avramovic G, Crowley D, Tinago W, Mafirakureva N, Cullen W. Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis. Interactive Journal of Medical Research 2022;11(2):e35300 View
  8. Chidwick K, Myton R, Rodgers A, Jun M, Dartnell J, Balcomb A, Dore G. A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC trial). Journal of Viral Hepatitis 2022;29(2):135 View
  9. Avramovic G, O’Doherty L, McHugh T, Remy A, Happiette A, Bouchkira H, Murat P, Scemama O, Esclade A, Farfan Camacho M, Cullen W, Lambert J. Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory. Viruses 2024;16(10):1645 View